Trinity Biotech (TRIB) Assets Average (2009 - 2025)

Trinity Biotech (TRIB) has reported Assets Average for 17 consecutive years, with $102.4 million the latest figure, recorded in Q4 2025.

• Quarterly Assets Average rose 2.02% year-over-year to $102.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $102.4 million (up 2.02% YoY) and the FY2025 annual result came in at $104.2 million, up 28.1% from the prior year.
• Assets Average grew to $102.4 million in Q4 2025 per TRIB's latest filing, from $101.5 million in the prior quarter.
• Over the last five years, Assets Average for TRIB reached as high as $133.2 million in Q1 2021 and fell as low as $61.5 million in Q4 2023.
• A 5-year average of $99.7 million and a median of $100.9 million in 2024 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2023 — Assets Average tumbled 35.25% — and 2024, when it jumped 63.16%.
• Year by year, Assets Average stood at $120.8 million in 2021, then slipped by 21.38% to $95.0 million in 2022, then tumbled by 35.25% to $61.5 million in 2023, then surged by 63.16% to $100.4 million in 2024, then increased by 2.02% to $102.4 million in 2025.
• According to Business Quant data, Assets Average over the past three periods registered $102.4 million, $101.5 million, and $100.4 million for Q4 2025, Q2 2025, and Q4 2024 respectively.